• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

综合分析结直肠癌 m6A 相关基因突变特征与预后。

Comprehensive analysis of m6A related gene mutation characteristics and prognosis in colorectal cancer.

机构信息

Department of Anal-Colorectal Surgery, General Hospital of Ningxia Medical University, 804 Shengli Road, Yinchuan, 750004, China.

School of Clinical Medicine, Ningxia Medical University, 1160 Shengli Road, Yinchuan, 750004, China.

出版信息

BMC Med Genomics. 2023 May 16;16(1):105. doi: 10.1186/s12920-023-01509-8.

DOI:10.1186/s12920-023-01509-8
PMID:37194014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10186803/
Abstract

BACKGROUND

Colorectal cancer is considered as the second most common cancer worldwide. Studies have shown that m6A RNA methylation abnormalities play an important role in the pathogenesis of many human diseases, including cancer. The current study was designed to characterize the mutation of m6A related genes and explore their prognostic role in colorectal cancer.

METHODS

RNA-seq data and somatic mutation data of TCGA-COAD and TCGA-READ were downloaded from UCSC xena for comprehensive analysis. M6A related genes were selected from previous literatures, including "Writer" protein (METTL3, METTL5, METTL14, METTL16, ZC3H13, RBM15, WTAP, KIAA1429), "Reader" protein YTHDF1, YTHDF2, YTHDF3, YTHDC1, YTHDC2, HNRNPC, IGF2BP1, IGF2BP2, IGF2BP3), and "Eraser" protein (FTO, ALKBH5). Kaplan-Meier diagrams were used to explore the correlation between m6A-related genes and colorectal cancer prognosis. The correlations between m6A-related genes and clinical parameters and immune-related indicators were explored by Spearman correlation analysis. And finally, the expression patterns of five key genes (RBMX, FMR1, IGF2BP1, LRPPRC and YTHDC2) were detected by qPCR in CRC specimens.

RESULTS

In CRC, the expressions of m6A-related genes were significantly different between CRC and normal control except METTL14, YTHDF2, YTHDF3. Some of CRC patients (178 in 536) have a m6A-related genes mutation. ZC3H13 has highest mutation frequency of all m6A-related genes. M6A-related genes mainly enrich in regulation of mRNA metabolic process pathway. Patients with high expressions of FMR1, LRPPRC, METTL14, RBMX, YTHDC2, YTHDF2, YTHDF3 have poor prognosis in CRC. There was a significant correlation between the FMR1, LRPPRC, RBMX, YTHDC2, IGF2BP1 expression and the clinical characteristics of CRC. In addition, these genes are significantly associated with immune-related indicators. According to the expression patterns of FMR1, LRPPRC, RBMX, YTHDC2, and IGF2BP1, patients with CRC were clustered into two groups, and their survival was significantly different. By evaluating the tumor microenvironment in two clusters using ssGSEA, expressions of immune checkpoints and GSVA enrichment analysis, we observed that the immune and stem cell index of two cluster were much different. The qPCR results showed that RBMX expression was markedly elevated in cancerous tissues than in the normal colonic tissues.

CONCLUSION

Our study identified novel prognostic markers associated with immune of CRC cancer patients. Moreover, the potential mechanisms of prognostic markers in regulating the etiology of CRC cancer were investigated. These findings enrich our understanding of the relationships between m6a related genes and CRC, and may provide novel ideas in the therapy of CRC patients.

摘要

背景

结直肠癌被认为是全球第二常见的癌症。研究表明,m6A RNA 甲基化异常在许多人类疾病的发病机制中发挥着重要作用,包括癌症。本研究旨在对 m6A 相关基因的突变进行特征描述,并探讨其在结直肠癌中的预后作用。

方法

从 UCSC xena 下载 TCGA-COAD 和 TCGA-READ 的 RNA-seq 数据和体细胞突变数据进行综合分析。m6A 相关基因是从先前的文献中选择的,包括“Writer”蛋白(METTL3、METTL5、METTL14、METTL16、ZC3H13、RBM15、WTAP、KIA A1429)、“Reader”蛋白 YTHDF1、YTHDF2、YTHDF3、YTHDC1、YTHDC2、HNRNPC、IGF2BP1、IGF2BP2、IGF2BP3)和“Eraser”蛋白(FTO、ALKBH5)。使用 Kaplan-Meier 图探讨 m6A 相关基因与结直肠癌预后的相关性。通过 Spearman 相关性分析探讨 m6A 相关基因与临床参数和免疫相关指标的相关性。最后,通过 qPCR 检测 CRC 标本中五个关键基因(RBMX、FMR1、IGF2BP1、LRPPRC 和 YTHDC2)的表达模式。

结果

在结直肠癌中,除了 METTL14、YTHDF2 和 YTHDF3 之外,CRC 和正常对照之间 m6A 相关基因的表达差异有统计学意义。部分 CRC 患者(536 例中有 178 例)存在 m6A 相关基因的突变。ZC3H13 是所有 m6A 相关基因中突变频率最高的。m6A 相关基因主要富集在调节 mRNA 代谢过程途径中。FMR1、LRPPRC、METTL14、RBMX、YTHDC2、YTHDF2 和 YTHDF3 高表达的患者在 CRC 中预后较差。FMR1、LRPPRC、RBMX、YTHDC2、IGF2BP1 的表达与 CRC 的临床特征之间存在显著相关性。此外,这些基因与免疫相关指标显著相关。根据 FMR1、LRPPRC、RBMX、YTHDC2 和 IGF2BP1 的表达模式,将 CRC 患者聚类为两组,其生存情况有显著差异。通过使用 ssGSEA 评估两组的肿瘤微环境,进行 GSVA 富集分析,我们观察到两组的免疫和干细胞指数有很大差异。qPCR 结果表明,RBMX 在癌组织中的表达明显高于正常结肠组织。

结论

本研究确定了与 CRC 癌症患者免疫相关的新型预后标志物。此外,还研究了预后标志物在调节 CRC 癌症发病机制中的潜在机制。这些发现丰富了我们对 m6A 相关基因与 CRC 之间关系的认识,可能为 CRC 患者的治疗提供新的思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9657/10186803/d256429858e8/12920_2023_1509_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9657/10186803/348f15837a67/12920_2023_1509_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9657/10186803/2ef0e37a7389/12920_2023_1509_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9657/10186803/4049481daba8/12920_2023_1509_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9657/10186803/4d6ee081b47f/12920_2023_1509_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9657/10186803/2df85e9ec38c/12920_2023_1509_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9657/10186803/51843f26bc83/12920_2023_1509_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9657/10186803/d256429858e8/12920_2023_1509_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9657/10186803/348f15837a67/12920_2023_1509_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9657/10186803/2ef0e37a7389/12920_2023_1509_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9657/10186803/4049481daba8/12920_2023_1509_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9657/10186803/4d6ee081b47f/12920_2023_1509_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9657/10186803/2df85e9ec38c/12920_2023_1509_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9657/10186803/51843f26bc83/12920_2023_1509_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9657/10186803/d256429858e8/12920_2023_1509_Fig7_HTML.jpg

相似文献

1
Comprehensive analysis of m6A related gene mutation characteristics and prognosis in colorectal cancer.综合分析结直肠癌 m6A 相关基因突变特征与预后。
BMC Med Genomics. 2023 May 16;16(1):105. doi: 10.1186/s12920-023-01509-8.
2
Characterizing m6A modification factors and their interactions in colorectal cancer: implications for tumor subtypes and clinical outcomes.表征结直肠癌中m6A修饰因子及其相互作用:对肿瘤亚型和临床结局的影响
Discov Oncol. 2024 Sep 18;15(1):457. doi: 10.1007/s12672-024-01298-1.
3
Constructing and validating of m6a-related genes prognostic signature for stomach adenocarcinoma and immune infiltration: Potential biomarkers for predicting the overall survival.构建和验证用于胃腺癌及免疫浸润的m6A相关基因预后特征:预测总生存期的潜在生物标志物
Front Oncol. 2022 Dec 22;12:1050288. doi: 10.3389/fonc.2022.1050288. eCollection 2022.
4
Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma.m6A甲基转移酶相关基因的鉴定可预测头颈部鳞状细胞癌的预后和免疫浸润情况。
Ann Transl Med. 2021 Oct;9(20):1554. doi: 10.21037/atm-21-4712.
5
The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome.RNA N6-甲基腺苷在原发性干燥综合征中的潜在作用。
Front Med (Lausanne). 2022 Nov 16;9:959388. doi: 10.3389/fmed.2022.959388. eCollection 2022.
6
m6A-Related Genes Contribute to Poor Prognosis of Hepatocellular Carcinoma.m6A 相关基因促进肝癌不良预后。
Comput Math Methods Med. 2022 Oct 26;2022:2427987. doi: 10.1155/2022/2427987. eCollection 2022.
7
m6A Regulators Is Differently Expressed and Correlated With Immune Response of Esophageal Cancer.m6A调控因子在食管癌中表达存在差异且与免疫反应相关。
Front Cell Dev Biol. 2021 Mar 4;9:650023. doi: 10.3389/fcell.2021.650023. eCollection 2021.
8
Pan-Cancer Prognostic, Immunity, Stemness, and Anticancer Drug Sensitivity Characterization of N6-Methyladenosine RNA Modification Regulators in Human Cancers.人类癌症中N6-甲基腺苷RNA修饰调节因子的泛癌预后、免疫、干性及抗癌药物敏感性特征分析
Front Mol Biosci. 2021 Jun 4;8:644620. doi: 10.3389/fmolb.2021.644620. eCollection 2021.
9
Abnormal genetic and epigenetic patterns of m6A regulators associated with tumor microenvironment in colorectal cancer.与结直肠癌肿瘤微环境相关的m6A调节因子的异常遗传和表观遗传模式。
Transl Cancer Res. 2023 Aug 31;12(8):2033-2047. doi: 10.21037/tcr-23-186. Epub 2023 Aug 28.
10
N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma.N6-甲基腺苷RNA甲基化调节因子相关的可变剪接基因特征作为低级别胶质瘤患者的预后预测指标及免疫微环境特征分析
Front Genet. 2022 Jul 22;13:872186. doi: 10.3389/fgene.2022.872186. eCollection 2022.

引用本文的文献

1
Regulatory mechanisms of m6A RNA methylation in esophageal cancer: a comprehensive review.食管癌中m6A RNA甲基化的调控机制:综述
Front Genet. 2025 Apr 22;16:1561799. doi: 10.3389/fgene.2025.1561799. eCollection 2025.
2
Landscape analysis of m6A modification regulators reveals LRPPRC as a key modulator in tubule cells for DKD: a multi-omics study.m6A修饰调节因子的景观分析揭示LRPPRC是糖尿病肾病肾小管细胞中的关键调节因子:一项多组学研究
Front Pharmacol. 2025 Apr 4;16:1506896. doi: 10.3389/fphar.2025.1506896. eCollection 2025.
3
Development and validation of a disulfidptosis-related prognostic model for colorectal cancer using multi-omics analysis.

本文引用的文献

1
T helper cell-mediated epitranscriptomic regulation via m6A RNA methylation bridges link between coronary artery disease and invasive ductal carcinoma.T 辅助细胞介导的 RNA 甲基化中介的转录组学调控通过 m6A 将冠状动脉疾病与浸润性导管癌联系起来。
J Cancer Res Clin Oncol. 2022 Dec;148(12):3421-3436. doi: 10.1007/s00432-022-04130-x. Epub 2022 Jul 1.
2
The N6-methyladenosine:mechanisms, diagnostic value, immunotherapy prospec-ts and challenges in gastric cancer.N6-甲基腺嘌呤:胃癌中的机制、诊断价值、免疫治疗前景及挑战
Exp Cell Res. 2022 Jun 15;415(2):113115. doi: 10.1016/j.yexcr.2022.113115. Epub 2022 Mar 24.
3
基于多组学分析的结直肠癌二硫键连接性坏死相关预后模型的构建与验证
Discov Oncol. 2025 Mar 17;16(1):338. doi: 10.1007/s12672-025-02055-8.
4
Mitochondrial Deoxyguanosine Kinase Induces 5-Fluorouracil Chemotherapy Sensitivity through Autophagy.线粒体脱氧鸟苷激酶通过自噬诱导5-氟尿嘧啶化疗敏感性。
Curr Cancer Drug Targets. 2025;25(3):306-316. doi: 10.2174/0115680096337375240801080008.
5
The biological function of the N6-Methyladenosine reader YTHDC2 and its role in diseases.N6-甲基腺苷阅读器 YTHDC2 的生物学功能及其在疾病中的作用。
J Transl Med. 2024 May 24;22(1):490. doi: 10.1186/s12967-024-05293-6.
6
METTL5 promotes cell proliferation, invasion, and migration by up-regulating Toll-like receptor 8 expression in colorectal cancer.METTL5通过上调结直肠癌中Toll样受体8的表达促进细胞增殖、侵袭和迁移。
World J Gastrointest Oncol. 2024 May 15;16(5):2006-2017. doi: 10.4251/wjgo.v16.i5.2006.
METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N-methyladenosine modification of PD-L1 mRNA in breast cancer.
METTL3/IGF2BP3 轴通过上调乳腺癌中 PD-L1 mRNA 的 N6-甲基腺苷修饰来抑制肿瘤免疫监视。
Mol Cancer. 2022 Feb 23;21(1):60. doi: 10.1186/s12943-021-01447-y.
4
Comprehensive analysis of N6-methylandenosine regulators and m6A-related RNAs as prognosis factors in colorectal cancer.N6-甲基腺苷调节剂和m6A相关RNA作为结直肠癌预后因素的综合分析
Mol Ther Nucleic Acids. 2021 Dec 14;27:598-610. doi: 10.1016/j.omtn.2021.12.007. eCollection 2022 Mar 8.
5
Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma.m6A甲基转移酶相关基因的鉴定可预测头颈部鳞状细胞癌的预后和免疫浸润情况。
Ann Transl Med. 2021 Oct;9(20):1554. doi: 10.21037/atm-21-4712.
6
mA regulators as predictive biomarkers for chemotherapy benefit and potential therapeutic targets for overcoming chemotherapy resistance in small-cell lung cancer.mA 调节剂作为预测化疗获益的生物标志物,以及克服小细胞肺癌化疗耐药性的潜在治疗靶点。
J Hematol Oncol. 2021 Nov 10;14(1):190. doi: 10.1186/s13045-021-01173-4.
7
ALKBH5 Facilitates Hypoxia-Induced Paraspeckle Assembly and IL8 Secretion to Generate an Immunosuppressive Tumor Microenvironment.ALKBH5 促进缺氧诱导的核小体组装和 IL8 分泌,以产生免疫抑制性肿瘤微环境。
Cancer Res. 2021 Dec 1;81(23):5876-5888. doi: 10.1158/0008-5472.CAN-21-1456. Epub 2021 Oct 20.
8
Incidence, mortality, survival, risk factor and screening of colorectal cancer: A comparison among China, Europe, and northern America.结直肠癌的发病率、死亡率、生存率、危险因素和筛查:中国、欧洲和北美之间的比较。
Cancer Lett. 2021 Dec 1;522:255-268. doi: 10.1016/j.canlet.2021.09.034. Epub 2021 Sep 24.
9
YTHDF1 and YTHDF2 are associated with better patient survival and an inflamed tumor-immune microenvironment in non-small-cell lung cancer.YTHDF1 和 YTHDF2 与非小细胞肺癌患者更好的生存和炎症肿瘤免疫微环境相关。
Oncoimmunology. 2021 Aug 10;10(1):1962656. doi: 10.1080/2162402X.2021.1962656. eCollection 2021.
10
The role of YTH domain containing 2 in epigenetic modification and immune infiltration of pan-cancer.YTH 结构域包含蛋白 2 在泛癌的表观遗传修饰和免疫浸润中的作用。
J Cell Mol Med. 2021 Sep;25(18):8615-8627. doi: 10.1111/jcmm.16818. Epub 2021 Jul 27.